Pterostilbene
Pterostilbene is a naturally occurring stilbene structurally similar to resveratrol but with two methoxy groups replacing hydroxyls, resulting in dramatically better oral bioavailability (80% vs ~1% for resveratrol) and longer half-life. It activates SIRT1 more potently than resveratrol and has superior CNS penetration. Found in blueberries and grapes at low concentrations. Human studies show cognitive improvements in older adults, improved blood pressure (-5-8 mmHg), and better glycemic control. The superior pharmacokinetics make pterostilbene strictly better than resveratrol for most brain- related outcomes. Often combined with resveratrol for complementary SIRT1 activation.
Evidence
No score yet
Safety
Unknown safety profile
Clinical Status
No formal phase listed
Research Sync
Not synced yet
Dosing
Pharmacology
Evidence Score
Plain-English Snapshot
Pterostilbene is currently categorized as a nootropic compound.
Evidence scoring has not been fully computed yet, so interpret this profile as preliminary.
Safety scoring is incomplete. Start conservatively and monitor carefully.
Core mechanism
SIRT1 activator (more potent than resveratrol); AMPK activation; superior BBB penetration; NF-kB inhibition; PPARα activation for fat oxidation; BDNF upregulation
Practical Context
Strongest current signals
No indexed study summaries yet.